Tenon Medical, Inc. (TNON) EBITDA Margin (2021 - 2026)
Tenon Medical (TNON) posted quarterly EBITDA Margin of 237.85% for Q1 2026, up 26862.0% year-over-year from N/an in Q1 2025, and down 22.91% quarter-over-quarter from 193.52% in Q4 2025.
Tenon Medical, Inc. (TNON) EBITDA Margin (2021 - 2026) Analysis & Trends
Tenon Medical's EBITDA Margin history runs 6 years deep, the most recent figure standing at 237.85% for Q1 2026.
- In Q1 2026, EBITDA Margin rose 26862.0% year-over-year to 237.85%; the TTM figure through Mar 2026 stood at 269.63% (up 15476.0% YoY), while the FY2025 annual figure was 324.34%, up 9574.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 237.85%, down from 193.52% in the prior quarter.
- The five-year high for EBITDA Margin was 193.52% in Q4 2025, with the low at 4041.48% in Q2 2022.
- The 5-year median for EBITDA Margin is 487.62% (2024), against an average of 1016.6%.
- The sharpest annual moves came in 2022 and 2023: EBITDA Margin sank 166817 bps in 2022, then soared 345979 bps in 2023.
- Tenon Medical's EBITDA Margin stood at 2862.09% in 2022, then jumped by 86 bps to 388.74% in 2023, then slipped by 6 bps to 412.08% in 2024, then jumped by 53 bps to 193.52% in 2025, then dropped by 23 bps to 237.85% in 2026.
- Business Quant data shows TNON's EBITDA Margin at 237.85% in Q1 2026, 193.52% in Q4 2025, and 289.17% in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -262.24% |
| Mar 31, 2026 | -237.85% |
| Dec 31, 2025 | -193.52% |
| Sep 30, 2025 | -289.17% |
| Jun 30, 2025 | -506.56% |
| Mar 31, 2025 | -506.47% |
| Dec 31, 2024 | -412.08% |
| Sep 30, 2024 | -362.46% |
| Jun 30, 2024 | -429.74% |
| Mar 31, 2024 | -487.62% |
| Dec 31, 2023 | -388.74% |
| Sep 30, 2023 | -357.84% |
| Jun 30, 2023 | -581.70% |
| Mar 31, 2023 | -1,128.41% |
| Dec 31, 2022 | -2,862.09% |
| Sep 30, 2022 | -1,568.27% |
| Jun 30, 2022 | -4,041.48% |
| Mar 31, 2022 | -2,928.17% |
| Dec 31, 2021 | -4,833.96% |
| Sep 30, 2021 | -2,995.71% |